TEKT4 and breast carcinoma: These findings indicate that whether Tekt4 inhibits or promotes tumour invasion depends on the tumour type and subtype, and that the presence of Tekt4 germline mutations can lead to resistance to chemotherapy in breast cancer and other tumours.